Document:

Exhibit 4.1

 

DESCRIPTION OF THE REGISTRANT’S SECURITIES

REGISTERED PURSUANT TO SECTION 12 OF THE

SECURITIES EXCHANGE ACT OF 1934

 

SunHydrogen, Inc. (the “Company”)
has one class of securities registered under Section 12 of the Securities Exchange Act of 1934, as amended, which is the Company’s
common stock, $0.001 par value per share.

 

Description of Common Stock

 

The authorized capital
stock of the Company consists of 5,000,000,000 shares of common stock at a par value of $0.001 per share, and 5,000,000 shares of blank
check preferred stock, par value $0.001.  

 

Holders of the Company’s common stock are entitled to one vote for each share on all matters submitted to a stockholder vote. Holders
of common stock do not have cumulative voting rights. Therefore (subject to the rights of the holders of any outstanding preferred
stock), holders of a majority of the shares of common stock voting for the election of directors can elect all of the directors to our
Board of Directors. Holders of the Company’s common stock representing a majority of the voting power of the Company’s
capital stock issued, outstanding and entitled to vote, represented in person or by proxy, are necessary to constitute a quorum at any
meeting of stockholders. A vote by the holders of a majority of the voting power of the stockholders is required to effectuate certain
fundamental corporate changes such as a merger or an amendment to the Company’s articles of incorporation.

 

Holders of the Company’s common stock are
entitled to share in all dividends that the Board of Directors, in its discretion, declares from legally available funds. In the
event of a liquidation, dissolution or winding up, each outstanding share entitles its holder to participate pro rata in all assets that
remain after payment of liabilities and after providing for each class of stock, if any, having preference over the common stock. The
Company’s common stock has no pre-emptive rights, no conversion rights, and there are no redemption provisions applicable to the
Company’s common stock.Exhibit 10.15

 

	 	Extension Agreement	 
	 	 	 
	 	between	 
	 	 	 
	SunHydrogen, Inc	 	 
	1OE Yanonali Street Suite 36

                                             Santa Barbara, CA 93101
	 	 
	 	 	 
	 	 	- "SUNHYDROGEN" -
	 	 	 
	 	and	 
	 	 	 
	Gebr. SCHMID GmbH

                                             Robert-Bosch-Strar.ie 32-36
	 	 
	72250 Freudenstadt

                                             Germany
	 	 
	 	 	 
	 	 	-"SCHMID" -

  

Recitals:

 

SCHMID has developed several tool and
process platforms for industrial processing of flat and continuous substrates for the electronic, PV, medical and commodity industries.
Besides having decades of experience in providing tools to the industry in the field of specialized immersion and single side chemical
treatment such as anodizing, chemical deburring, etching, cleaning and chemical bath deposition, electro and electroless plat ing, thin
film deposition in ambient and low pressure environment, one of the major strengths of the company is to industrialize processes from
lab to mass manufacturing.

 

SUNHYDROGEN has developed a breakthrough
nanoparticle technology to make green hydrogen using sunlight and any source of water. SUNHYDROGEN seeks to identify and develop manufacturing
processes to scale-up second generation ("Gen2") nanoparticle technology to transition from lab-scale to commercial scale.

 

SUNHYDROGEN and SCHMID have entered
into a Cooperation Agreement with an effective date March 1, 2021 ("Cooperation Agreement") with a duration of 6 months.
SUNDHYDROGEN and SCHMID intend to extend the Cooperation Agreement until De cember 31, 2021.

 

    Page 1  of 2

     

    

 

	1.	Extention

 

In order
to satisfy its respective obligations in accordance with the Cooperation Agreement, SUNHYDROGEN and SCHMID hereby agree to extend the
Cooperation Agreement until December 31, 2021 ("Extension Period").

 

	2.	Miscellaneous

 

All provisions of the Cooperation Agreement
will remain in full force and effect unless amended in this Extension Agreement. If there is a conflict between this Extension Agreement
and the Cooperation Agreement, this Extension Agreement will prevail.

 

	Freudenstadt,
    September 28, 2021	 	Santa
    Barbara, September 28, 2021
	 	 	 
	Gebr.
    SCHMID GmbH	 	SunHydrogen
    Inc.
	 	 	 
	/s/
    Christian Schmid	 	 
	Name:
    Christian Schmid	 	Name:
    Tim Young
	 	 	 
	Title: CEO	 	Title:
    CEO

 

 

Page 2 of 2Exhibit 10.16

 

CONTRACT # K311000-C

 

THIS AGREEMENT
effective this 1st of September 2021, by and between SunHydrogen, Inc (hereafter referred to as “Sponsor”) and
The University of Iowa, Iowa City, Iowa, a non-profit educational institution (hereinafter referred to as “University”).

 

WITNESSETH:

 

WHEREAS, the research
program contemplated by this Agreement is of mutual interest and benefit to University and to Sponsor, will further the instructional
and research objectives of University in a manner consistent with its status as a non- profit, tax-exempt, educational institution, and
may derive benefits for both Sponsor and University through inventions, improvements, and/or discoveries;

 

NOW, THEREFORE,
in consideration of the premises and mutual covenants herein contained, the parties hereto agree to the following:

 

ARTICLE 1 - Definitions

 

As used herein, the
following terms shall have the following meanings:

 

		1.1	“Project”
shall mean the description of the project as described in Exhibit A hereof, under the direction of Syed Mubeen as Principal Investigator.

 

		1.2	“Contract Period” is Sep 1, 2021, through
Aug 31, 2022.

 

		1.3	“University Intellectual
Property” shall mean individually and collectively all inventions, improvements and/or discoveries which are conceived and/or made
(i) by one or more employees of University, or (ii) jointly by one or more employees of University and by one or more employees/consultants
of Sponsor, in performance of the Project.

 

ARTICLE 2 - Research Work

 

		2.1	University shall commence
performance of the Project promptly after the effective date of this Agreement, and shall use all reasonable efforts, care, and diligence
to perform such Project in accordance with the terms and conditions of this Agreement. Anything in this Agreement to the contrary notwithstanding,
Sponsor and University may at any time amend the Project by mutual written agreement.

 

		2.2	In the event that the
Principal Investigator becomes unable or unwilling to continue the Project, and a mutually acceptable substitute is not available, University
and/or Sponsor shall have the option to terminate said Project pursuant to Article 10.1.

 

		2.3	The University does not
comply with Good Laboratory Practices (GLPs) as defined by the U.S. Food and Drug Administration in 21 C.F.R. 58.

 

    -1-

     

    

 

ARTICLE 3 - Reports and Conferences

 

		3.1	Written program reports
shall be provided by University to Sponsor every six (6) months, and a final report shall be submitted by University within forty-five
(45) days of the conclusion of the Contract Period, or the earlier termination of this Agreement.

 

		3.2	During the term of this
Agreement, representatives of University will meet with representatives of Sponsor at times and places mutually agreed upon to discuss
the progress and results, as well as ongoing plans, or changes therein, of the Project to be performed hereunder.

 

ARTICLE 4 - Costs, Billings,
and Other Support

 

		4.1	It
                                            is agreed to and understood by the parties hereto that, subject to Article 2, total costs
                                            to Sponsor hereunder shall not exceed the sum of Three Hundred Fifty Thousand Dollars
                                            ($350,000). Payment shall be made by Sponsor according to the following schedule:
                                            Four (4) Quarterly Payments of $87,500

 

		4.2	Invoices shall be submitted
to the Sponsor representative listed in Article 17 for submission of invoices. Payments to University shall include Sponsor name, Principal
Investigator name, project title and shall be submitted to the University representative listed in Article 17 for payment remittance.

 

		4.3	University shall retain
title to any equipment purchased with funds provided by Sponsor under this Agreement.

 

		4.4	Anything herein to the
contrary notwithstanding, in the event of early termination of this Agreement by Sponsor pursuant to Article 10.1 hereof, Sponsor shall
pay all costs accrued by University as of the date of termination, including non-cancelable obligations, which shall include all non-cancelable
contracts and fellowships or postdoctoral associate appointments called for in Appendix A, incurred prior to the effective date of termination.
After termination, any obligation of Sponsor for fellowships or postdoctoral associates shall end no later than the end of University’s
academic year following termination.

 

ARTICLE 5 - Publicity

 

		5.1	Sponsor shall not use the name of University, nor of any member of University’s
Project staff, in any publicity, advertising, or news release or in any way imply endorsement of the University without the prior written
approval of an authorized representative of University. University shall not use the name of Sponsor, nor any employee of Sponsor, in
any publicity without the prior written approval of Sponsor. University may disclose, without Sponsor’s approval, the terms of this
Agreement that are a matter of public record under the Iowa Open Records Law, Iowa Code Chapter 22.

 

ARTICLE 6 - Publications

 

		6.1	Sponsor recognizes that under University policy, the results of University research
must be publishable and agrees that researchers engaged in the Project shall be permitted to present research results at symposia, national
or regional professional meetings, and to publish in journals, theses or dissertations, or otherwise of their own choosing, methods and
results of the Project, provided, however, that Sponsor shall have been furnished copies of any proposed publication or presentation at
least one (1) month in advance of the submission of such proposed publication or presentation to a journal, editor, or other third party.
Sponsor shall have thirty (30) days, after receipt of said copies, to object to such proposed presentation or proposed publication because
there is patentable subject matter or proprietary information of Sponsor that needs protection. In the event that Sponsor makes such objection,
said researcher(s) shall refrain from making such publication or presentation for a maximum of six (6) months from date of receipt of
such objection in order for University to file patent application(s) with the United States Patent and Trademark Office and/or foreign
patent office(s) directed to the patentable subject matter contained in the proposed publication or presentation. Sponsor does not possess
a right to delay publication if the publication or presentation contains only findings and conclusions of basic science or results that
would not affect the ability of Sponsor to obtain a patent.

 

    -2-

     

    

 

ARTICLE 7 - Proprietary Information

 

		7.1	It is the responsibility
of Sponsor to mark or otherwise identify in writing prior to submission any information considered confidential that it deems necessary
to share with University (“Confidential Information”). Oral disclosures of Confidential Information shall be identified as
confidential at the time of disclosure and confirmed in writing within ten (10) business days of the disclosure. University shall have
the right to accept or reject Sponsor’s Confidential Information. If such information is accepted it will be withheld by University
from publication, and in all other respects shall be maintained by University as confidential and proprietary to Sponsor for a period
of five (5) years after
termination of this Agreement. University shall have no such obligation with respect to any portion of such Confidential Information which:

 

		a)	is or later becomes generally
available to the public by use, publication or the like, through no fault of University;

 

		b)	is obtained on a non-confidential
basis from a third party who disclosed the same to University;

 

		c)	University already possesses,
as evidenced by its written records, predating receipt thereof from Sponsor; or

 

		d)	is required to be disclosed by law, regulation
or court order.

 

		7.2	All documentation concerning
University Intellectual Property submitted to Sponsor in accordance with Article 8.4 shall be treated as confidential in order to preserve
any patent rights.

 

ARTICLE 8 - Intellectual Property

 

		8.1	All rights, title and
interest to University Intellectual Property under the Project, except as provided in Article 8.3, shall belong to University and shall
be subject to the terms and conditions of this Agreement.

 

		8.2	Rights to inventions, improvements, and/or
                                                               discoveries, whether patentable or copyrightable or not, relating to the Project made solely by employees /consultants
of Sponsor shall belong to Sponsor. Such inventions, improvements, and/or discoveries shall not be subject to the terms and conditions
of this Agreement.

 

		8.3	Rights to inventions,
improvements, and/or discoveries conceived and/or made during the Contract Period, whether patentable or copyrightable or not, relating
to the Project, which are made jointly by employees of University and employees/consultants of Sponsor, shall be the joint property of
University and Sponsor and shall be subject to the terms and conditions of this Agreement.

 

		8.4	University will promptly
notify Sponsor of any University Intellectual Property conceived and/or made during the Contract Period under the Project. If Sponsor
directs that a patent application or application for other intellectual property protection be filed, University shall promptly prepare,
file, and prosecute such U.S. and foreign application in University’s name, and Sponsor’s name if jointly invented. Sponsor shall
bear all costs incurred in connection with such preparation, filing, prosecution, and maintenance of U.S. and foreign
application(s) directed to said University Intellectual Property. Sponsor shall cooperate with University to assure that such application(s)
will cover, to the best of Sponsor’s knowledge, all items of commercial interest and importance. While University shall be responsible
for making decisions regarding scope and content of application(s) to be filed and prosecution thereof, Sponsor shall be given an opportunity
to review and provide input thereto. University shall keep Sponsor advised as to all developments with respect to such application(s)
and shall promptly supply to Sponsor copies of all papers received and filed in connection with the prosecution thereof in sufficient
time for Sponsor to comment thereon.

 

		8.5	If Sponsor elects not
to exercise its option granted in Article 9.1 or decides to discontinue the financial support of the prosecution and maintenance of the
patent protection, all right, title and interest in such patent, patent application, and University Intellectual Property shall automatically
revert to University. University shall then be free to file or continue prosecution or maintain any such application(s), and to maintain
any protection issuing thereon in the U.S. and in any foreign country at University’s sole expense.

 

    -3-

     

    

 

ARTICLE 9 - Grant of Rights

 

		9.1	Subject to Article 8.3,
University grants Sponsor the first option to elect an exclusive license to University Intellectual Property developed under this Agreement,
and a right to sub-license any and all University Intellectual Property developed under this Agreement on terms and conditions to be mutually
agreed upon. If Sponsor elects to exercise this option, Sponsor shall notify University
in writing of its decision within one (1) year from the date of termination of this Agreement.

 

		9.2	No grant described in
this Article shall be construed to limit University’s right to utilize University Intellectual Property for research, instruction
or academic publication purposes.

 

ARTICLE 10 - Term and Termination

 

		10.1	This Agreement shall
become effective upon the date first hereinabove written and shall continue in effect for the full duration of the Contract Period unless
sooner terminated in accordance with the provisions of this Article. The parties hereto may, however, extend the term of this Agreement
for additional periods as desired under mutually agreeable terms and conditions which the parties reduce to writing and sign. Either party
may terminate this Agreement upon sixty (60) days prior written notice to the other.

 

		10.2	In the event that either
party hereto shall commit any material breach or default in any of the terms or conditions of this Agreement, and also shall fail to remedy
such default or breach within ninety (90) days after receipt of written notice thereof from the other party hereto, the party giving notice
may, at its option and in addition to any other remedies which it may have at law or in equity, terminate this Agreement by sending notice
of termination in writing to the other party to such effect, and such termination shall be effective as of the date of the receipt of
such notice.

 

		10.3	Termination of this Agreement
by either party for any reason shall not affect the rights and obligations of the parties accrued prior to the effective date of termination
of this Agreement. No termination of this Agreement, however effectuated, shall release the parties hereto from their rights and obligations
under Articles 3.1, 4, 5, 6, 7, 8, 9 and 11.

 

ARTICLE 11 - Independent Contractor

 

		11.1	In the performance of all services hereunder University shall
be deemed to be and shall be an independent contractor and, as such, University shall not be entitled to any benefits applicable to employees
of Sponsor.

 

		11.2	Neither party is authorized or empowered to act as agent for the other for any
purpose and shall not on behalf of the other enter into any contract, warranty, or representation as to any matter. Neither shall be bound
to the acts or conduct of the other.

 

ARTICLE 12 – Insurance

 

		12.1	Each party shall be liable
for any and all claims for wrongful death, personal injury or property damage attributable to the negligent acts or omissions of that
party and the officers, employees, and agents thereof.

 

    -4-

     

    

 

		12.2	University shall be responsible
and agrees to pay for any and all claims for wrongful death, personal injury or property damage directly resulting from the negligence
of University, its officers, employees and agents, and arising from activities under this Agreement to the full extent permitted by Chapter
669, Code of Iowa, which is the exclusive remedy for processing tort claims against the State of Iowa.

 

ARTICLE 13 - Governing Law

 

		13.1	This Agreement shall be governed and construed in accordance with the substantive
laws of the State of Iowa, excluding its conflict of laws provisions.

 

ARTICLE 14 - Assignment

 

		14.1	This Agreement shall
not be assigned by either party without the prior written consent of the parties hereto.

 

		14.2	This Agreement is assignable
to any division of Sponsor, any majority stockholder of Sponsor, and/or any subsidiary of Sponsor, provided that such assignee assumes
all of the rights, obligations and liabilities of Sponsor hereunder.

 

ARTICLE 15 - Agreement Modification

 

		15.1	Any agreement to change the terms of this Agreement in any way shall be valid
only if the change is made in writing and approved by mutual agreement of authorized representatives of the parties hereto.

 

ARTICLE 16 - Warranties

 

		16.1	NO WARRANTIES, EITHER EXPRESSED OR IMPLIED, ARE MADE PART OF THIS AGREEMENT.

 

ARTICLE 17 – Export
Control

 

		17.1	The disclosing party agrees to share any export control determinations when products,
services, and/or technical data under this Agreement are subject to export controls under U.S. Government export laws and regulations;
however, each party will be solely responsible for compliance with U.S. Government export laws and regulations.

 

ARTICLE 18 - Notices

 

		18.1	Notices, invoices, and
communications, hereunder shall be given by registered or certified mail, or express delivery service, postage or delivery charge prepaid,
and addressed to the party to receive such notice, invoice, or communication at the address given below, or such other address as may
hereafter be designated by notice in writing. Notice shall be deemed made on the date of receipt.

 

    -5-

     

    

 

If to Sponsor:

 

Woosuk Kim, COO SunHydrogen, Inc

Phone:

E-mail:tyoung@sunhydrogen.com

 

For Submission of Invoices:

 

SunHydrogen, Inc.

32 E. Micheltorena, Suite A

Santa Barbara, CA 93101

Phone:

Fax: 805-617-3601

E-mail: tyoung@sunhydrogen.com

 

		If to University:	    The University of Iowa

Division of Sponsored Programs Attention:

2 Gilmore Hall

Iowa City, Iowa 52242 Phone:

E-mail:

 

For Payment Remittance:

 

The University of Iowa Grant Accounting Office 2410 UCC,
201 S Clinton St

Iowa City, Iowa 52242-1316

Phone: 319-335-3801

Fax: 319-335-0674

 

IN WITNESS WHEREOF,
the parties, duly authorized, have executed this Agreement in duplicate as of the day and year first written above.

 

	SUNHYDROGEN, INC. (SPONSOR)	 	THE UNIVERSITY OF IOWA
	 	 	 
	 	 	 
	By: 	Woosuk Kim	 	By: 	Wendy Beaver
	Title:	COO	 	Title:	Executive Director of Sponsored Programs
	 	 	 	 
	Date:	 	 	Date:	 
	 	 	 	 

 

Rev. 03/30/2012

 

 

-6-

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00334-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00334-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00334-of-00352.parquet"}]]